SA is launching a six-month pilot programme to help doctors become practice owners and healthcare entrepreneurs, reported The Citizen (22 April 2026).
The SA Health Products Regulatory Authority (SAHPRA) is facing pressure over plans to phase out oral phenylephrine in OTC cold and flu products due to doubts about its effectiveness. The move follows scrutiny by the US Food and Drug Administration, which found the ingredient ineffective at standard doses.
SA’s two major union federations, Cosatu and Fedusa, have escalated their warning that the country’s healthcare funding model is pricing workers out of cover. This follows GEMS’s 9.8% increase in medical scheme tariffs in January 2026. – TimesLive (22 April 2026)
New surveillance data from the National Institute for Communicable Diseases (NICD) between 29 December 2025 and 12 April 2026 revealed 1,076 laboratory-confirmed measles cases nationally. – TimesLive (21 April 2026).